Allianz Asset Management GmbH boosted its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 38.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 233,348 shares of the health services provider's stock after buying an additional 64,249 shares during the quarter. Allianz Asset Management GmbH owned 0.41% of Maximus worth $16,381,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC boosted its stake in Maximus by 67.1% during the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares during the period. Blue Trust Inc. boosted its stake in Maximus by 32.8% during the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after buying an additional 303 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Maximus during the first quarter worth $2,115,000. Janney Montgomery Scott LLC boosted its stake in Maximus by 70.5% during the first quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after buying an additional 4,196 shares during the period. Finally, Oppenheimer Asset Management Inc. boosted its stake in Maximus by 24.0% during the first quarter. Oppenheimer Asset Management Inc. now owns 6,461 shares of the health services provider's stock worth $441,000 after buying an additional 1,249 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on MMS shares. Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 26th. Weiss Ratings raised shares of Maximus from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. According to MarketBeat, Maximus has a consensus rating of "Buy" and a consensus target price of $90.00.
Read Our Latest Stock Analysis on Maximus
Maximus Stock Up 2.3%
NYSE:MMS opened at $87.15 on Tuesday. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.73. The company has a 50-day moving average of $87.56 and a 200 day moving average of $76.88. The firm has a market cap of $4.91 billion, a PE ratio of 16.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the firm earned $1.74 earnings per share. The firm's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Friday, November 14th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio is 22.10%.
Insiders Place Their Bets
In other Maximus news, insider Michelle F. Link sold 1,610 shares of the business's stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider directly owned 13,508 shares in the company, valued at approximately $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by company insiders.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.